| Michele C. Mckinnie, Psy.d., Pc | |
|
1648 Ellis St Suite 302 Bozeman MT 59715-8810 | |
| (406) 582-1321 | |
| (406) 587-1513 |
| Full Name | Michele C. Mckinnie, Psy.d., Pc |
|---|---|
| Speciality | Psychologist |
| Location | 1648 Ellis St, Bozeman, Montana |
| Authorized Official Name and Position | Michele Catherine Mckinnie (PSYCHOLOGIST/OWNER) |
| Authorized Official Contact | 4065821321 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Michele C. Mckinnie, Psy.d., Pc 1648 Ellis St Suite 302 Bozeman MT 59715-8810 Ph: (406) 582-1321 | Michele C. Mckinnie, Psy.d., Pc 1648 Ellis St Suite 302 Bozeman MT 59715-8810 Ph: (406) 582-1321 |
| NPI Number | 1083896757 |
|---|---|
| Provider Enumeration Date | 12/04/2007 |
| Last Update Date | 12/04/2007 |
| Medicare PECOS PAC ID | 2668412339 |
|---|---|
| Medicare Enrollment ID | O20071211000080 |
News Archive
An international team of Canadian and Spanish scientists have found the first potential immunological clue of why some people develop severe pneumonia when infected by the pandemic H1N1 virus.
Patients with pulmonary arterial hypertension struggle with severe symptoms, which include shortness of breath, exhaustion and a lack of vitality. Moreover, the disease, which is more common in women, often claims the patient's life within a few years of its development.
Braeburn Pharmaceuticals, an Apple Tree Partners company, today reported positive topline results from the Phase 3 double-blind, double-dummy clinical study of Probuphine, the investigational subdermal implant containing buprenorphine HCl for the long-term maintenance treatment of opioid addiction.
Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083896757 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 338 (Montana) | Primary |
| Provider Name | Michele C Mckinnie |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1902969983 PECOS PAC ID: 9537146097 Enrollment ID: I20040701001361 |
News Archive
An international team of Canadian and Spanish scientists have found the first potential immunological clue of why some people develop severe pneumonia when infected by the pandemic H1N1 virus.
Patients with pulmonary arterial hypertension struggle with severe symptoms, which include shortness of breath, exhaustion and a lack of vitality. Moreover, the disease, which is more common in women, often claims the patient's life within a few years of its development.
Braeburn Pharmaceuticals, an Apple Tree Partners company, today reported positive topline results from the Phase 3 double-blind, double-dummy clinical study of Probuphine, the investigational subdermal implant containing buprenorphine HCl for the long-term maintenance treatment of opioid addiction.
Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.
› Verified 2 days ago
News Archive
An international team of Canadian and Spanish scientists have found the first potential immunological clue of why some people develop severe pneumonia when infected by the pandemic H1N1 virus.
Patients with pulmonary arterial hypertension struggle with severe symptoms, which include shortness of breath, exhaustion and a lack of vitality. Moreover, the disease, which is more common in women, often claims the patient's life within a few years of its development.
Braeburn Pharmaceuticals, an Apple Tree Partners company, today reported positive topline results from the Phase 3 double-blind, double-dummy clinical study of Probuphine, the investigational subdermal implant containing buprenorphine HCl for the long-term maintenance treatment of opioid addiction.
Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.
› Verified 2 days ago
Mindful Healing Therapy And Recovery, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1174 Stoneridge Dr Ste 304, Bozeman, MT 59718 Phone: 406-414-7055 | |
Annemarie Dubois, Lcsw, L.l.c Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1351 Stoneridge Dr Ste D, Bozeman, MT 59718 Phone: 802-999-4559 | |
Catherine Anne Maclean Phd Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3825 Valley Commons Drive, Suite 4, Bozeman, MT 59718 Phone: 406-585-9890 Fax: 406-556-2173 | |
Illuminate Counseling And Coaching Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2291 Caballo Ave Unit 1, Bozeman, MT 59718 Phone: 406-587-1535 Fax: 406-303-4031 | |
406 Recovery Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 5 W Mendenhall St Ste 202, Bozeman, MT 59715 Phone: 406-219-7233 | |
Creating Choices Pc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 65b W Kagy Blvd, Bozeman, MT 59715 Phone: 406-585-7167 | |
Carly's Counseling Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2023 Stadium Dr Ste 2b-209, Bozeman, MT 59715 Phone: 406-219-7841 |